MGRX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Mangoceuticals Inc (MGRX).


$6.02M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

MGRX Market Cap. (MRY)


MGRX Shares Outstanding (MRY)


MGRX Assets (MRY)


Total Assets

$15.37M

Total Liabilities

$1.43M

Total Investments

$0

MGRX Income (MRY)


Revenue

$615.87K

Net Income

-$8.71M

Operating Expense

$8.35M

MGRX Cash Flow (MRY)


CF Operations

-$4.86M

CF Investing

$65.00K

CF Financing

$4.13M

MGRX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

-

-

0%

-

MGRX Balance Sheet (MRY)


Metric

2024

2023

2022

Total Assets

$15,370,511 (1362.75%)

$1,050,793 (4.74%)

$1,003,287

Assets Current

$75,595 (-90.76%)

$818,460 (17.83%)

$694,605

Assets Non-Current

$15,294,916 (6483.19%)

$232,333 (-24.73%)

$308,682

Goodwill & Intangible Assets

$15,232,617 (0%)

$0 (0%)

$0

Shareholders Equity

$13,946,129 (1700.07%)

$774,754 (26.18%)

$614,030

Property Plant & Equipment Net

$62,299 (-71.08%)

$215,391 (-26.17%)

$291,740

Cash & Equivalents

$75,595 (-90.00%)

$755,948 (8.02%)

$699,802

Accumulated Other Comprehensive Income

-$9,845 (0%)

$0 (0%)

$0

Deferred Revenue

$0 (0%)

$0 (0%)

$0

Total Investments

$0 (0%)

$0 (0%)

$0

Investments Current

$0 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$18,501 (0%)

$0

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Payables

$837,501 (494.96%)

$140,765 (318.01%)

$33,675

Accumulated Retained Earnings (Deficit)

-$20,806,595 (-85.31%)

-$11,228,173 (-457.02%)

-$2,015,756

Tax Assets

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$6,595 (142.73%)

$2,717

Total Debt

$214,962 (67.05%)

$128,679 (-63.53%)

$352,865

Debt Current

$214,962 (237.36%)

$63,718 (-71.58%)

$224,185

Debt Non-Current

$0 (0%)

$64,961 (-49.52%)

$128,680

Total Liabilities

$1,425,463 (416.40%)

$276,039 (-29.09%)

$389,257

Liabilities Current

$1,425,463 (575.33%)

$211,078 (-19.00%)

$260,577

Liabilities Non-Current

$0 (0%)

$64,961 (-49.52%)

$128,680

MGRX Income Statement (MRY)


Metric

2024

2023

2022

Revenues

$615,873 (-15.81%)

$731,493 (8083.16%)

$8,939

Cost of Revenue

$235,909 (-21.36%)

$299,992 (7236.56%)

$4,089

Selling General & Administrative Expense

$5,996,764 (-19.99%)

$7,495,277 (275.43%)

$1,996,432

Research & Development Expense

$0 (0%)

$0 (0%)

$0

Operating Expenses

$8,351,957 (-13.45%)

$9,650,391 (383.38%)

$1,996,432

Interest Expense

$13,700 (0%)

$0 (0%)

$6,473

Income Tax Expense

$0 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$8,707,226 (5.48%)

-$9,212,417 (-361.07%)

-$1,998,055

Net Income to Non-Controlling Interests

-$1,081 (0%)

$0 (0%)

$0

Net Income

-$8,706,145 (5.50%)

-$9,212,417 (-361.07%)

-$1,998,055

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$8,706,145 (5.50%)

-$9,212,417 (-361.07%)

-$1,998,055

Weighted Average Shares

$1,978,966 (-87.72%)

$16,113,029 (49.22%)

$10,798,083

Weighted Average Shares Diluted

$1,978,966 (-87.72%)

$16,113,029 (49.22%)

$10,798,083

Earning Before Interest & Taxes (EBIT)

-$8,692,445 (5.64%)

-$9,212,417 (-362.57%)

-$1,991,582

Gross Profit

$379,964 (-11.94%)

$431,501 (8796.93%)

$4,850

Operating Income

-$7,971,993 (13.53%)

-$9,218,890 (-362.89%)

-$1,991,582

MGRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

Net Cash Flow from Investing

$65,000 (1947.12%)

-$3,519 (91.84%)

-$43,102

Net Cash Flow from Financing

$4,128,268 (-41.50%)

$7,057,040 (244.26%)

$2,049,930

Net Cash Flow from Operations

-$4,863,776 (30.49%)

-$6,997,375 (-419.66%)

-$1,346,518

Net Cash Flow / Change in Cash & Cash Equivalents

-$670,508 (-1294.22%)

$56,146 (-91.50%)

$660,310

Net Cash Flow - Business Acquisitions and Disposals

$65,000 (0%)

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0

Capital Expenditure

$0 (0%)

-$3,519 (91.84%)

-$43,102

Issuance (Repayment) of Debt Securities

$150,000 (189.57%)

-$167,460 (-435.39%)

$49,930

Issuance (Purchase) of Equity Shares

$1,328,268 (-81.61%)

$7,224,500 (261.23%)

$2,000,000

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

-$9,845 (0%)

$0 (0%)

$0

Share Based Compensation

$2,354,947 (9.27%)

$2,155,114 (178.38%)

$774,153

Depreciation Amortization & Accretion

$731,469 (2838.92%)

$24,889 (544.29%)

$3,863

MGRX Financial Metrics (MRY)


Metric

2024

2023

2022

Gross Margin

61.70% (4.58%)

59.00% (8.66%)

54.30%

Profit Margin

-1413.60% (-12.24%)

-1259.40% (94.37%)

-22352.10%

EBITDA Margin

-1292.60% (-2.91%)

-1256.00% (94.35%)

-22236.50%

Return on Average Equity (ROAE)

-86.60% (78.97%)

-411.70% (38.46%)

-669.00%

Return on Average Assets (ROAA)

-76.20% (79.20%)

-366.40% (5.93%)

-389.50%

Return on Sales (ROS)

-1411.40% (-12.07%)

-1259.40% (94.35%)

-22279.70%

Return on Invested Capital (ROIC)

892.90% (129.49%)

-3028.20% (-200.89%)

-1006.40%

Dividend Yield

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-0.5 (-2.88%)

-0.49

-

Price to Sales Ratio (P/S)

7.78 (27.50%)

6.1

-

Price to Book Ratio (P/B)

0.43 (-94.62%)

8.01

-

Debt to Equity Ratio (D/E)

0.1 (-71.35%)

0.36 (-43.85%)

0.63

Earnings Per Share (EPS)

-4.84 (-749.12%)

-0.57 (-200.00%)

-0.19

Sales Per Share (SPS)

0.31 (591.11%)

0.04 (4400.00%)

0

Free Cash Flow Per Share (FCFPS)

-2.46 (-466.36%)

-0.43 (-236.43%)

-0.13

Book Value Per Share (BVPS)

7.05 (14581.25%)

0.05 (-15.79%)

0.06

Tangible Assets Book Value Per Share (TABVPS)

0.07 (7.69%)

0.07 (-30.11%)

0.09

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1

-

Enterprise Value Over EBITDA (EV/EBITDA)

-0.78 (-40.18%)

-0.56

-

Asset Turnover

0.05 (-81.44%)

0.29 (1611.76%)

0.02

Current Ratio

0.05 (-98.63%)

3.88 (45.46%)

2.67

Dividends

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$4,863,776 (30.53%)

-$7,000,894 (-403.80%)

-$1,389,620

Enterprise Value (EV)

$6,195,512 (21.54%)

$5,097,696

-

Earnings Before Tax (EBT)

-$8,706,145 (5.50%)

-$9,212,417 (-361.07%)

-$1,998,055

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$7,960,976 (13.35%)

-$9,187,528 (-362.21%)

-$1,987,719

Invested Capital

-$1,148,202 (-640.47%)

$212,446 (-46.32%)

$395,773

Working Capital

-$1,349,868 (-322.24%)

$607,382 (39.94%)

$434,028

Tangible Asset Value

$137,894 (-86.88%)

$1,050,793 (4.74%)

$1,003,287

Market Capitalization

$6,017,359 (-3.07%)

$6,207,960

-

Average Equity

$10,051,712 (349.17%)

$2,237,860 (649.31%)

$298,655

Average Assets

$11,425,456 (354.38%)

$2,514,536 (390.24%)

$512,918

Invested Capital Average

-$973,551 (-420.02%)

$304,218 (53.73%)

$197,886

Shares

2,486,512 (-88.91%)

22,419,500 (63.47%)

13,715,000